Physician profile
Bernard B Baez
NPI 1053393751
$2,035.39
in general payments reported to CMS, 2019-2025
22 companies · $751 in 2025
The $751 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $111 · 2021: $168 · 2022: $263 · 2023: $271 · 2024: $256 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $390.11 | 2019-2025 | Caldolor |
| Aop Health US, LLC | $304.55 | 2025 | Rapiblyk |
| Abiomed | $276.17 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $186.88 | 2019-2024 | Bridion, Dificid |
| Chiesi USA, INC. | $182.81 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.02 | 2022-2025 | Entyvio |
| Boston Scientific Corporation | $112.09 | 2021 | |
| Janssen Biotech, INC. | $100.01 | 2022-2025 | Tremfya, Stelara |
| Edwards Lifesciences Corporation | $79.16 | 2022 | |
| W. L. Gore & Associates, INC. | $63.72 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Celltrion USA INC. | $35.09 | 2025 | Vegzelma |
| Avanos Medical | $28.64 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $26.86 | 2019 | |
| Abbvie INC. | $21.22 | 2023 | Rinvoq |
| Pacira Pharmaceuticals Incorporated | $15.06 | 2023 | Zilretta, Exparel, Iovera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $14.95 | 2025 | |
| Mallinckrodt Enterprises LLC | $14.59 | 2019 | |
| Intercept Pharmaceuticals, INC. | $14.49 | 2022 | |
| Masimo Corporation | $14.31 | 2024 | Set and Rainbow Set |
| Mallinckrodt Hospital Products INC. | $14.25 | 2020 | |
| Heron Therapeutics, INC. | $13.78 | 2022 | |
| Baudax Bio INC. | $13.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Baez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.